Richard Fair

Chief Executive Officer at ENLIVEN THERAPEUTICS, INC.

57 year

Health Technology

Consumer Services

Distribution Services

Profile

Mr. Richard A. Fair is a Chief Executive Officer & Director at Enliven Therapeutics, Inc. /US/, a President, Chief Executive Officer & Director at Enliven Therapeutics, Inc. and a President & Director at Bellicum Pharmaceuticals, Inc. He is on the Board of Directors at Enliven Therapeutics, Inc. /US/, Enliven Therapeutics, Inc. and Bellicum Pharmaceuticals, Inc. Mr. Fair was previously employed as an Independent Director by Clovis Oncology, Inc., a SVP & Head-Therapeutic Oncology Global Product by Genentech, Inc., and a Franchise Head-Hematology by Roche Pharma (Schweiz) AG.
He received his undergraduate degree from the University of Michigan and an MBA from Columbia Business School.

Richard Fair active positions

Companies	Position	Start
BELLICUM PHARMACEUTICALS, INC.	President	31/01/2017
ENLIVEN THERAPEUTICS, INC.	Chief Executive Officer	11/12/2025
Enliven Therapeutics, Inc. /US/ Enliven Therapeutics, Inc. /US/ BiotechnologyHealth Technology Engages in discovery and development of small molecule treatments for cancer	Chief Executive Officer	11/12/2025

All active positions of Richard Fair

Former positions of Richard Fair

Companies	Position	End
CLOVIS ONCOLOGY, INC.	Director/Board Member	10/07/2023
Genentech, Inc. Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples	Corporate Officer/Principal	01/01/2017
Roche Pharma (Schweiz) AG Roche Pharma (Schweiz) AG Medical DistributorsDistribution Services Wholesales pharmaceutical products	Corporate Officer/Principal	-

See the detail of Richard Fair's experience

Education of Richard Fair

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Richard Fair's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	8
Genentech, Inc. Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples	Health Technology
Bellicum Pharmaceuticals, Inc. Bellicum Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel cellular immunotherapies for various forms of cancer	Health Technology
University of Michigan University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Clovis Oncology, Inc. Clovis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as an biopharmaceutical company that acquires, develops and commercializes innovative anti cancer agents	Health Technology
Roche Pharma (Schweiz) AG Roche Pharma (Schweiz) AG Medical DistributorsDistribution Services Wholesales pharmaceutical products	Distribution Services
Columbia Business School Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Enliven Therapeutics, Inc. /US/ Enliven Therapeutics, Inc. /US/ BiotechnologyHealth Technology Engages in discovery and development of small molecule treatments for cancer	Health Technology
Enliven Therapeutics, Inc. Enliven Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage precision oncology company that develops molecule therapies	Health Technology